In 2007, the World Health Organization and UNAIDS proved that circumcised men reduce their risk of HIV Infection by 60% in high risk areas such as Sub-Saharan Africa.
The Circ MedTech team developed the patent pending PrePex device to achieve rapid scale-up of voluntary medical male circumcision (VMMC) in resource limited settings, prevalent in Sub-Saharan Africa. PrePex is the first known device to facilitate non-surgical MC that can claim all of the following: No injected anesthesia. No surgery. No sutures and No sterile settings.
The guiding principle of the company is to offer safe, simple, scalable and cost effective male circumcision programs that can be implemented by minimally skilled healthcare workers.
PrePex was extensively reviewed by the WHO, with its safety and efficacy validated in a series of comprehensive, rigorous studies. For a list of WHO Prequalified VMMC devices Click here
PrePex is Class II CE certified and a sterile version for adults has been cleared by the FDA. PrePex is manufactured using USP Class VI biocompatible elastomeric materials compliant to ISO_13485 Medical Devices (Quality Management systems) and FDA, 21 CFR177. 2600. Circ MedTech is ISO 13485 certified.